Allison works at the intersection of neuromodulation and behavior change with specific interest in interoceptive circuits.  Her primary tools of inquiry are human brain electrophysiology and psychophysiological measures.  Allison completed her training at Stanford University, University of Oregon, University of Arizona, and Emory University.  She is a practicing clinical psychologist and the director of the lab.

Aashna is developing a treatment response biomarker for patients undergoing deep brain stimulation for treatment resistant depression. Her research examines electrocortical excitability changes within the subcallosal cingulate, default mode network and other brain networks over the course treatment with DBS. Aashna received her B.A. in Neurobiology from the University of California, Berkeley and her M.S. in Biomedical Sciences with an emphasis in Neuroscience from the Icahn School of Medicine at Mount Sinai. 

Tine is currently pursuing her PhD at KU Leuven and is a visiting researcher in the lab.  Her research focuses on using perturbation mapping to uncover the working mechanisms of DBS in treating OCD and dystonia, and to explore the use of evoked potentials as a clinical biomarker.  Tine received her MSc in Bioscience Engineering and MSc in Artificial Intelligence from the KU Leuven.

Claudia is a Master’s student at the Icahn School of Medicine at Mount Sinai, where she studies physiological and behavioral markers of interoception in treatment-resistant depression. Claudia is interested in translating neurophysiological insights into scalable, data-driven health technologies. She earned her BS in Neuroscience and Cognitive Science from the University of Arizona.